Loading chat...
OR HB2103
Bill
Status
Failed
6/27/2025
Primary Sponsor
Virgle Osborne
Click for details
AI Summary
- Directs the State Board of Pharmacy to adopt rules classifying xylazine as a Schedule IV controlled substance
- Adds new provisions to Oregon Revised Statutes sections 475.005 to 475.285 governing controlled substances
- Sponsored by Representative Osborne and filed as a presession bill for the 2025 Regular Session
- Xylazine is a veterinary sedative that has increasingly appeared as an adulterant in illicit drug supplies
Legislative Description
Relating to xylazine.
Last Action
In committee upon adjournment.
6/27/2025
Committee Referrals
Behavioral Health and Health Care1/17/2025
Full Bill Text
No bill text available